A61K 2039/62
Medicinal preparations containing antigens or antibodies: characterised by the link between antigen
Official title: {characterised by the link between antigen and carrier}
A61K2039/62 (Medicinal preparations containing antigens or antibodies: characterised by the link between antigen) appears on 727 US grants and 1,139 published applications in this corpus.
Search patents in A61K- Granted patents
- 727
- Published applications
- 1,139
- Assignees
- 555
- Inventors
- 1,993
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 11 | 0 |
| 1998 | 15 | 0 |
| 1999 | 10 | 0 |
| 2000 | 18 | 0 |
| 2001 | 11 | 1 |
| 2002 | 23 | 23 |
| 2003 | 7 | 34 |
| 2004 | 11 | 34 |
| 2005 | 2 | 17 |
| 2006 | 9 | 23 |
| 2007 | 10 | 22 |
| 2008 | 5 | 27 |
| 2009 | 16 | 37 |
| 2010 | 11 | 31 |
| 2011 | 12 | 38 |
| 2012 | 15 | 29 |
| 2013 | 18 | 34 |
| 2014 | 23 | 42 |
| 2015 | 41 | 58 |
| 2016 | 34 | 69 |
| 2017 | 38 | 51 |
| 2018 | 37 | 64 |
| 2019 | 44 | 52 |
| 2020 | 48 | 73 |
| 2021 | 39 | 65 |
| 2022 | 34 | 62 |
| 2023 | 43 | 73 |
| 2024 | 50 | 67 |
| 2025 | 37 | 74 |
| 2026 | 18 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for inducing immune tolerance8 Sep 2026US 12,728,155 B2Anokion SA
- Production of MHC II/CII complexes1 Sep 2026US 12,721,884 B2
- Therapeutic anticancer neoepitope vaccine4 Aug 2026US 12,697,377 B2Nykode Therapeutics ASA
- Alphavirus neoantigen vectors and interferon inhibitors16 Jun 2026US 12,653,883 B2Seattle Project Corp.
- Anti-parasitic immunological compositions9 Jun 2026US 12,648,993 B2Board of Regents of the University of Nebraska
- Programmably degradable hydrogels for functional molecular release1 Oct 2026US 2026/0294805 A1Georgia Tech Research Corporation
- Peptide conjugated particles24 Sep 2026US 2026/0284162 A1Northwestern University
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Vaccines targeting pseudomonas aeruginosa10 Sep 2026US 2026/0265312 A1Evaxion Biotech A/S
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
Most cited
By later US patents
- Conformationally-restricted combinatiorial library composition and method117US 5,824,483 APence, Inc. · 1998
- Recombinant toxin fragments113US 6,461,617 B1Microbiological Research Authority · 2002
- Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy109US 5,830,464 AFordham University · 1998
- Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases108US 5,837,251 AFordham University · 1998
- Immunotherapeutic stress protein-peptide complexes against cancer102US 5,750,119 AMount Sinai School of Medicine of the City University of New York · 1998